Zymeworks (ZYME) News Today $10.75 +0.12 (+1.13%) (As of 07/26/2024 ET) Add Compare Share Share HeadlinesStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsTrendsStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsTrends All Sources Trusted Sources MarketBeat.com Benzinga Bloomberg MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha The Street The Wall Street Journal Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 September 2022 August 2022 July 2022 June 2022 May 2022 April 2022 March 2022 February 2022 January 2022 December 2021 November 2021 October 2021 September 2021 August 2021 Time Period July 25 at 4:30 PM | globenewswire.comZymeworks Appoints Leone Patterson as Chief Business and Financial OfficerJuly 25 at 2:52 AM | marketbeat.comZymeworks (ZYME) to Release Earnings on ThursdayZymeworks (NYSE:ZYME) will be releasing earnings after the market closes on Thursday, August 1, Zacks reports. (Register for Conference Call at http://mmm.wallstreethorizon.com/u.asp?u=607766)July 24 at 5:03 PM | marketbeat.comZymeworks Inc. (NYSE:ZYME) Holdings Increased by O Shaughnessy Asset Management LLCO Shaughnessy Asset Management LLC grew its stake in shares of Zymeworks Inc. (NYSE:ZYME - Free Report) by 51.5% during the first quarter, according to its most recent filing with the Securities and Exchange Commission. The institutional investor owned 255,497 shares of the company's stock after bJuly 22, 2024 | markets.businessinsider.comFDA Clears IND Application Of Zymeworks For ZW191July 22, 2024 | marketbeat.comZymeworks Inc. (NYSE:ZYME) Shares Sold by Jupiter Asset Management Ltd.Jupiter Asset Management Ltd. lessened its stake in Zymeworks Inc. (NYSE:ZYME - Free Report) by 13.8% during the 1st quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The firm owned 426,944 shares of the company's stock after selling 68,638 shares durinJuly 22, 2024 | marketwatch.comZymeworks Shares Rise After FDA Clears Cancer Drug ApplicationJuly 22, 2024 | globenewswire.comZymeworks Announces FDA Clearance of Investigational New Drug Application for ZW191, a Novel Folate Receptor-⍺ Targeted Topoisomerase I Inhibitor Antibody-Drug ConjugateJuly 19, 2024 | marketbeat.comZymeworks Inc. (NYSE:ZYME) Shares Sold by Picton Mahoney Asset ManagementPicton Mahoney Asset Management decreased its stake in shares of Zymeworks Inc. (NYSE:ZYME - Free Report) by 20.3% in the 1st quarter, according to its most recent Form 13F filing with the SEC. The fund owned 284,378 shares of the company's stock after selling 72,528 shares during the period. PictoJuly 18, 2024 | marketbeat.comZymeworks (NYSE:ZYME) Shares Gap Down to $10.35Zymeworks (NYSE:ZYME) Shares Gap Down to $10.35July 16, 2024 | marketbeat.com55,079 Shares in Zymeworks Inc. (NYSE:ZYME) Purchased by Susquehanna Fundamental Investments LLCSusquehanna Fundamental Investments LLC acquired a new stake in Zymeworks Inc. (NYSE:ZYME - Free Report) in the 1st quarter, according to the company in its most recent filing with the SEC. The firm acquired 55,079 shares of the company's stock, valued at approximately $579,000. Susquehanna FundameJuly 11, 2024 | globenewswire.comZymeworks To Report Second Quarter 2024 Financial Results and Host Conference Call on August 1, 2024July 9, 2024 | seekingalpha.comZymeworks: A Somewhat Complicated StoryJune 21, 2024 | marketbeat.comQ2 2024 Earnings Forecast for Zymeworks Inc. Issued By HC Wainwright (NYSE:ZYME)Zymeworks Inc. (NYSE:ZYME - Free Report) - Research analysts at HC Wainwright decreased their Q2 2024 earnings per share (EPS) estimates for Zymeworks in a research report issued on Tuesday, June 18th. HC Wainwright analyst R. Burns now forecasts that the company will post earnings per share of (June 17, 2024 | globenewswire.comZymeworks Announces FDA Clearance of Investigational New Drug Application for ZW171, a novel 2+1 T-cell Targeting Bispecific Antibody for Mesothelin-expressing CancersJune 16, 2024 | marketbeat.comPerceptive Advisors LLC Cuts Stock Position in Zymeworks Inc. (NYSE:ZYME)Perceptive Advisors LLC lessened its position in Zymeworks Inc. (NYSE:ZYME - Free Report) by 25.7% during the 4th quarter, according to its most recent filing with the Securities and Exchange Commission. The firm owned 1,074,807 shares of the company's stock after selling 371,316 shares during theJune 11, 2024 | marketbeat.comZymeworks (NYSE:ZYME) Stock Price Up 5.7%Zymeworks (NYSE:ZYME) Trading 5.7% HigherJune 10, 2024 | globenewswire.comZymeworks Announces China NMPA Acceptance of Biologics License Application for Zanidatamab for Second-Line Treatment of Biliary Tract CancerJune 9, 2024 | marketbeat.comRubric Capital Management LP Purchases 823,990 Shares of Zymeworks Inc. (NYSE:ZYME)Rubric Capital Management LP increased its position in shares of Zymeworks Inc. (NYSE:ZYME - Free Report) by 31.1% during the fourth quarter, according to its most recent filing with the Securities & Exchange Commission. The fund owned 3,475,384 shares of the company's stock after acquiring anJune 6, 2024 | marketbeat.comZymeworks' (ZYME) "Neutral" Rating Reiterated at HC WainwrightHC Wainwright restated a "neutral" rating and set a $10.00 target price on shares of Zymeworks in a research report on Thursday.June 3, 2024 | marketbeat.comZymeworks (NYSE:ZYME) Trading 8.4% Higher Zymeworks (NYSE:ZYME) Stock Price Up 8.4%May 29, 2024 | markets.businessinsider.comZymeworks Inc. (ZYME) Shareholders May Have Been Affected by Fraud- Levi & Korsinsky InvestigatesMay 28, 2024 | globenewswire.comZymeworks Announces Participation in Upcoming Investor ConferencesMay 21, 2024 | finance.yahoo.comZymeworks Provides Corporate Update and Reports First Quarter 2024 Financial ResultsMay 21, 2024 | finance.yahoo.comZymeworks Inc. (NASDAQ:ZYME) Consensus Forecasts Have Become A Little Darker Since Its Latest ReportMay 20, 2024 | marketbeat.comAssenagon Asset Management S.A. Acquires Shares of 166,549 Zymeworks Inc. (NYSE:ZYME)Assenagon Asset Management S.A. acquired a new stake in shares of Zymeworks Inc. (NYSE:ZYME - Free Report) in the 1st quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The institutional investor acquired 166,549 shares of the company's stock,May 16, 2024 | businesswire.comKirby McInerney LLP is Investigating Potential Shareholder Claims Against Zymeworks Inc. (ZYME)May 9, 2024 | markets.businessinsider.comStifel Nicolaus Reaffirms Their Buy Rating on Zymeworks (ZYME)May 8, 2024 | markets.businessinsider.comHold Rating on Zymeworks: Balancing Potential Rewards and Valuation RisksMay 7, 2024 | benzinga.comZymeworks Stock: A Deep Dive Into Analyst Perspectives (5 Ratings)May 6, 2024 | prnewswire.comSHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Zymeworks Inc. - ZYMEMay 3, 2024 | marketbeat.comZymeworks (NYSE:ZYME) Price Target Lowered to $16.00 at CitigroupCitigroup dropped their price target on Zymeworks from $17.00 to $16.00 and set a "buy" rating on the stock in a research note on Friday.May 3, 2024 | markets.businessinsider.comOptimistic Buy Rating for Zymeworks: Anticipated Approvals and Strong Pipeline PotentialMay 3, 2024 | markets.businessinsider.comBuy Rating Affirmed for Zymeworks on Strong Pipeline and Upcoming CatalystsMay 3, 2024 | finance.yahoo.comZymeworks Inc. (NYSE:ZYME) Q1 2024 Earnings Call TranscriptMay 3, 2024 | finance.yahoo.comZymeworks Inc (ZYME) (Q1 2024) Earnings Call Transcript Highlights: Navigating Challenges and ...April 30, 2024 | globenewswire.comZymeworks Announces Participation in Upcoming Investor ConferencesApril 28, 2024 | prnewswire.comSHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Zymeworks Inc. - ZYMEApril 20, 2024 | prnewswire.comSHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Zymeworks Inc. - ZYMEApril 19, 2024 | marketbeat.comZymeworks (NYSE:ZYME) Shares Up 3.5%Zymeworks (NYSE:ZYME) Trading Up 3.5%April 18, 2024 | seekingalpha.comBuy Zymeworks Pioneering Cancer Treatments: Zanidatamab's Promising DataApril 16, 2024 | markets.businessinsider.comLevi & Korsinsky Reminds Shareholders of an Investigation into Zymeworks Inc. (ZYME) Regarding Potential Securities Fraud AllegationsApril 12, 2024 | markets.businessinsider.comMaintaining Hold on Zymeworks: ZW191’s Potential Amidst Competitive and Regulatory HurdlesApril 12, 2024 | prnewswire.comSHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Zymeworks Inc. - ZYMEApril 11, 2024 | globenewswire.comZymeworks To Report First Quarter 2024 Financial Results and Host Conference Call on May 2, 2024April 9, 2024 | marketbeat.comZymeworks (NYSE:ZYME) Trading Down 2.6%Zymeworks (NYSE:ZYME) Shares Down 2.6%April 8, 2024 | globenewswire.comZymeworks Presents New Data from Multiple Preclinical Development Programs at 2024 American Association for Cancer Research Annual MeetingApril 4, 2024 | prnewswire.comSHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Zymeworks Inc. - ZYMEApril 4, 2024 | morningstar.comKirby McInerney LLP Announces Investigation of Shareholder Claims Against Zymeworks Inc. (ZYME)April 2, 2024 | stockhouse.comSHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Zymeworks Inc. - ZYMEApril 1, 2024 | marketbeat.comZymeworks (NYSE:ZYME) Stock Price Down 6.7%Zymeworks (NYSE:ZYME) Stock Price Down 6.7% Get Zymeworks News Delivered to You Automatically Sign up to receive the latest news and ratings for ZYME and its competitors with MarketBeat's FREE daily newsletter. Email Address top AI stock (it’s not MSFT, GOOGL, AMZN or AAPL) (Ad)AI was by far the biggest tech investing trend right now. But Ross Givens says the #1 artificial intelligence stock[/lin] is NOT Microsoft, Google, Amazon or Apple. Nope — his research is pointing to a tiny, under-the-radar stock that’s trading for just a few dollars right now… And could soon shoot to the moon, handing early investors a windfall. Click here now for the full details of this stock that’s set to rocket in the AI revolution… ZYME Media Mentions By Week ZYME Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. ZYME News Sentiment▼0.640.62▲Average Medical News Sentiment ZYME News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. ZYME Articles This Week▼82▲ZYME Articles Average Week Get Zymeworks News Delivered to You Automatically Sign up to receive the latest news and ratings for ZYME and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies: BHC News SWTX News AMRX News DCPH News PTGX News CPRX News ARVN News SNDX News AMPH News ZLAB News Headlines Tools: Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NYSE:ZYME) was last updated on 7/26/2024 by MarketBeat.com Staff From Our Partners625,000% GainImagine swapping your daily coffee expense for a future free of financial worries. It might seem far-fetche...Crypto Swap Profits | Sponsored“Generational Bull Run” IncomingLIVE Cash Flow Workshop Event / Hosted Virtually Weds @ 7PM EST Everyone who attends will also receive 3 sp...Unstoppable Prosperity | SponsoredThis student turned $1,300 into $45,000 in just 4 Months!With the help of S.A.M. (my new AI-powered scanner) it's now easier than ever to find these unique trades... ...Monument Traders Alliance | SponsoredRare signal predicts 50% market drop - before electionThe market is near all-time highs, we're told that unemployment is low, AI's a gift to humanity, and the FED w...Behind the Markets | SponsoredMust-See: Elon’s New Invention is Absolutely InsaneCould Elon's New Device be Bigger than the iPhone? According to 30-year Silicon Valley and Wall Street vete...InvestorPlace | SponsoredElon to Transform U.S. Economy? A radical, potentially game-changing technology that threatens to destroy the trillion-dollar, “green energy” ...Porter & Company | Sponsored5 Stocks that could triple in a week Robinhood traders have piled $78 billion into this market... Driving tiny tech stock gains of 3,000%, 8,942...Traders Agency | SponsoredMusk’s new company could top a trillion?The investment legend who predicted the rise of Bitcoin, Facebook and streaming services like Netflix… Just...Paradigm Press | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Zymeworks Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Zymeworks With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
